• Profile
Close

Efficacy and safety of sitagliptin added to treatment of patients with type 2 diabetes inadequately controlled with premixed insulin

Diabetes, Obesity and Metabolism Jan 18, 2019

Yu M, et al. - In the present study, researchers tested the effectiveness and safety of adding sitagliptin to the treatment of patients with type 2 diabetes taking premixed insulin. Data from patients using premixed insulin ± metformin were analyzed in either of two clinical trials in which sitagliptin 100 mg once-daily or placebo was added to various formulations of insulin treatment. They found a significant improvement in glycemic control in patients with premixed insulin with sitagliptin, with no statistically significant differences in symptomatic or severe hypoglycemia incidences. This investigation confirmed the usefulness of sitagliptin used in combination with premixed insulin in type 2 diabetes patients.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay